Study Design. Retrospective study. Objective. To determine the malignancy rate and histology in bone biopsies obtained during PVP for VCF. Summary of Background Data. Osteoporotic vertebral compression fractures (VCF) affect approximately 20% of postmenopausal women and can lead to long-term disability. Percutaneous vertebroplasty (PVP) is a minimally invasive procedure, primarily used in patients with severe pain after VCF. Even with a thorough clinical examination, magnetic resonance imaging (MRI) scans, and blood samples, some fractures maybe caused by an underlying malignant disease. Methods. 144 consecutive patients underwent PVP for painful VCF, at the Center for Spine Surgery and Research, Middelfart Hospital. All patients had bone biopsies obtained during the PVP, and these biopsies were sent to the Department for Pathology at Vejle Sygehus for histologic diagnosis. Results. About 144 patients were included in this study. The majority of the biopsy specimens (137, 95.1%) were acceptable for histological diagnosis. One hundred and twenty nine (89.6%) biopsies showed no signs of malignancy. Seven (4.9 %) were positive for malignancy. One biopsy was positive for MGUS. Seven (4.9 %) of the biopsies were unsuitable for histologic diagnosis. Conclusion. Our study shows an incidence of unsuspected malignancy in biopsies during PVP of 4.9%. Conservative treatment with analgesics and brace can potentially delay diagnosis and treatment of underlying malignant disease. We recommend biopsy during PVP as a standard procedure, to insure not to overlook any underlying malignancy despite the MRI-scan, blood analysis, and clinical examination being inconspicuous. Key words: bone biopsy, malignancy, osteoporosis, pVP, spine surgery, vertebral compression fractures. 1 Percutaneous vertebroplasty (PVP) is a minimally invasive procedure, first described in 1987 primarily to treat painful hemangiomas in the spine. During PVP, 2 to 4 cc of bone cement is inserted in the vertebral body under fluoroscopic guidance via either a transpedicular or extrapedicular approach.
O steoporotic vertebral compression fractures affect approximately 20% of postmenopausal women and can lead to long-term immobility and disability. 1 Percutaneous vertebroplasty (PVP) is a minimally invasive procedure, first described in 1987 primarily to treat painful hemangiomas in the spine. During PVP, 2 to 4 cc of bone cement is inserted in the vertebral body under fluoroscopic guidance via either a transpedicular or extrapedicular approach. 2 PVP is described as a safe procedure, and has been performed in different areas of the spine (C2-S1). [3] [4] [5] Following two randomized double-blind studies published in 2009 by Buchbinder et al 6 and Kallmes et al, 7 questioning the effectiveness of PVP, there has been an ongoing debate whether vertebral compression fractures should be treated operatively or nonoperatively. In 2013, a study by Nuti et al showed that undiagnosed vertebral compression fractures were found in almost 25% of their study population of 2450 women without back pain, and that the severity of the fractures was strongly correlated with worsening of health status as assessed by QUALEFRO. 1 A recent study by Chou reported an incidence of undiagnosed malignancy of 3.8% in the group of patients with vertebral compression fractures. 8 Thus, unsuspected malignancy as a cause of the pathologic fracture should be considered when treating these patients.
The purpose of this retrospective study is to describe the prevalence of unsuspected malignancy in biopsies from a group of 144 consecutive patients who underwent PVP for suspected osteoporotic vertebral compression fractures. All MRI scans were evaluated by a radiologist and a spine surgeon prior to surgery and all patients suspected for malignancy were referred to an oncologist department for further diagnostic evaluation, and were excluded from this study. The patients underwent a medical examination and a standard preoperative blood analysis including CRP (C-reactive protein). Prior to the referral to PVP incl. biopsy, all patients underwent conservative treatment with optimal pain medication by the referring doctor.
METHODS
All PVPs were performed within 8 weeks of a low-energy trauma, resulting in back pain. Patients were placed in prone position on the surgical table, and the levels were marked prior to the procedure which under during fluoroscopic guidance. Biopsies were obtained with an 11 G Osteo-Site 1 Bone Biopsy Needle, COOK Medical, and the size of the biopsies are 10Â3 mm, with 11 G equivalent to 3 mm in diameter. All procedures were performed under local anesthesia with Lidocaine 10 mg/mL injected subcutaneous and at the periostal border of the bone entry point. Although all patients were surgically prepared for general anesthesia, no complication occurred during any of the PVPs and all patients tolerated the procedure under local anesthesia. No postoperative complications occurred.
Under fluoroscopic guidance, the 11 G Biopsy Needle were inserted through the vertebral pedicles and a biopsy was obtained from the fractured vertebrae. If two fractured vertebrae were treated, only the most compressed vertebra was biopsied.
All biopsies obtained during the surgical procedures were routinely processed at the Department of Clinical Pathology, Vejle Hospital. After fixation in Lillie's AAF (ethanol, acetic acid formaldehyde) the biopsies were decalcified in buffered formic acid before dehydration and embedding in paraffin. Histological, 4 mm thick, HE-stained tissue sections were evaluated morphologically. If malignancy was suspected, the morphological examination was supplied by immunohistochemical analysis, in which antibodies were selected by the pathologist directed by the suspected kind of malignancy (e.g., cytokeratin 7 and 20 for metastatic carcinoma, CD138 for multiple myeloma, etc.).
Patients received information about the biopsy, and if malignancy was present the patient was referred to further examination and treatment.
RESULTS
A total of 144 patients were included in this study, 1 biopsy was obtained from each patient. Patient demographics are shown in Table 1 . Flowchart with the results of the biopsies was displayed in Figure 1 . The majority of the biopsy specimens 137 (95.1%) biopsies were acceptable for histological diagnosis (Figure 1) . A total of 129 of the biopsies (89.6%) showed no signs of malignancy. Seven (4.9%) of the biopsies were positive for malignancy. Four biopsies showed Lymphoma, 2 biopsies showed Multiple Myeloma and Carcinoma metastasis. One biopsy showed MGUS, a possible but not definite precursor for multiple Myeloma. Figure 2 shows MRI scans, STIR sequence from 2 different patients, and all though not all modalities of the MRI are shown, this illustrates the difficulties of distinguishing between benign and malignant on a MRI. The biopsy of the patient in Figure 2A showed small-cell lymphoma, while the biopsy of the patient in Figure 2B showed osteoporotic changes in the bone, but no malignant cells. The patient with small cell lymphoma was a 60-year old lady, with no prior history of malignant diseases. The patient was referred to a hematologic department for further examination and was treated with chemotherapy. She is alive, currently not receiving any treatment 2 years after diagnosis, and the disease has not developed any further. 
DISCUSSION
The usual diagnostic tools for evaluating vertebral compression fractures (VCF) are X-ray, computed tomography (CT) Scans, MRI-and/or DEXA-scans. Previous reports have shown that MRI has the best accuracy in detecting malignancy with a sensitivity between 55% and 94 %. [9] [10] [11] Our study shows a malignancy rate of 4.9%, despite all patients in this study having a preoperative MRI scan showing no evidence of malignancy. Unfortunately, 4.9% of the biopsies were unsuitable for histological diagnosis, due to a lack of tissue represented in the biopsy, and the frequency of malignancy could potentially be higher. In our study the 11 G needle were used for the bone biopsy procedure, as suggested by our pathology department. Very few complications are reported after the removal of a bone biopsy, in local anaesthetic 12 and our patients tolerate the discomfort during the bone biopsy well. No major complication occurred during the procedure or postoperatively. If more than one fracture was present at the time of biopsy, only the most severe fractured vertebrae were biopsied.
Our quality of bone biopsy's are comparable with previous studies, by Moller et al 12 and Pierot et al 13 who used comparable Jamshidi 3.1 mm needles, which is the Golden standard in many diagnostic Centers. A larger needle could ensure a better detection rate of malignancies, and reduce the number of crush artifacts, but would also increase the risk of perioperative bleeding, pneumothorax, development of postoperative hematomas or needle tract seeding.
14,15 A recent study by Mukherjee et al finds in a sample of 147 consecutive collected patients treated for VCF over a 5-year period, a rate of unsuspected malignancy of 4.7%, which support our findings. 16 Muijs et al reports as high as 7.4 % of malignancy in their PVP cohort, where the bone biopsy's are also collected prior to PVP treatment. 17 The high number of unsuspected malignancy is surprising, while all patients in our patient group were screened with preoperative blood samples and 50% of the patients included were referred from other hospital departments, e.g., endocrinological, hematological, or orthopedic departments, due to the treatment resistant pain. The etiology of malignancies found is typical for cancers with a slow development, and 50% of all patients diagnosed with multiple myelomas suffer from one or more vertebral fractures, at the time of diagnosis. 18 Pathological examination should be considered in patients with low energy trauma, since early diagnosis plays an important role for the patient's prognosis. A further advantage is that a PVP procedure to stabilize the vertebrae, can be performed afterwards as described in several studies. [12] [13] [14] [15] [16] [17] 19 
CONCLUSION
Our study shows an incidence of unsuspected malignancy in biopsies during PVP procedure of 4.9%. We recommend perioperative bone biopsies in all patients undergoing PVP procedures to insure not to overlook any underlying malignancy despite the MRI-scan, blood analysis, and clinical examination being inconspicuous.
Key Points
About 249 consecutive patients underwent PVP for painful VCF, at the Center for Spine Surgery and Research, Middlefart Hospital. All patients had bone biopsies obtained during the PVP, and these biopsies were sent to the Department for Pathology at Vejle Sygehus for histologic diagnosis. After excluding patients with prior and current malignancy, 144 patients were included in this study. The majority of the biopsy specimens (137, 95.1%) were acceptable for histological diagnosis. Eight (5.6%) were positive for malignancy. We recommend biopsy during PVP as a standard procedure, to insure not to overlook any underlying malignancy despite the MRI-scan, blood analysis, and clinical examination being inconspicuous.
